Overview

Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Meditoxin® in the treatment of Essential blepharospasm.
Phase:
Phase 4
Details
Lead Sponsor:
Medy-Tox
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA